Single blood eosinophil count accurately predicts ICS treatment response in COPD

A single blood eosinophil count taken in patients with COPD can predict treatment response to inhaled corticosteroids (ICS) just as accurately as two measurements, UK researchers have shown. An Oxford University team undertook a post-hoc analysis of data from the randomised InforMing the PAthway of COPD Treatment (IMPACT)  trial to assess whether one or two ...

Already a member?

Login to keep reading.

© 2022 the limbic